Healthy Longevity Global Grand Challenge. NAM22I0007. | Blood-borne components from pregnant females as a novel therapeutic avenue against Alzheimer’s disease. | 2022-2023
Abstract: Alzheimer’s disease (AD) has no cure and the current therapies approved against AD are only palliatives. However, an ideal treatment should be capable of halting brain deterioration. In this regard, one of the research lines of our institute focuses on the identification and study of the role of peripheral factors present in the blood […]
